Phoenixin is a neuropeptide involved in reproductive neuroendocrinology, anxiety, and pain. Researchers investigate its diverse roles in the brain and its potential therapeutic applications.
In the literature, Phoenixin appears most often in work focused on fertility, anxiety and pain research. Studies in this area tend to look at mechanisms and observed effects in laboratory and preclinical settings rather than outcomes in people, so the picture is best read as a map of where researchers have been curious — not as evidence of any benefit.
Because it is catalogued here under powder peptides, Phoenixin also shows up in discussions of neuroprotection. Coverage across those topics varies widely in quality and depth, and much of it is early-stage. Reading the underlying research directly is the only way to judge how strong any particular finding is.
Tap a topic to see which peptides are most studied for it.
Atosiban is a synthetic competitive antagonist of the oxytocin receptor, developed to suppress premature uterine contractions. It is used as a tocolytic agent to treat preterm labor.
A neuropeptide preparation studied for neuroprotection, cognitive function, and recovery after brain injury.
A potent opioid-receptor peptide used strictly in analgesic and receptor research.
Research use only. This page summarizes areas of published study and is not medical advice. No dosing, protocol, or usage guidance is provided.